Eliminate data silos and discover more
Properly informed decisions in drug development can reduce costs and accelerate the road to market. Yet gaining new insights relies on access to relevant and accurate data. Still, having access to data is not the same as having answers.
Normalizing and organizing life science data from disparate sources in integrated silos facilitates the ability for researchers to compare, analyze, interpret and share data. This broader access and potential for collaboration increases the opportunities to drive pharmaceutical research in innovative directions.
Maximize R&D productivity and reduce IT costs
Elsevier is more than an information provider. It's a trusted partner in the curation, normalization and integration of life science data. Composed of experts in life sciences research and informatics solutions, the R&D Solutions Professional Services team enables customers to increase R&D productivity, increase the return on information and reduce the cost of IT support.
Drawing on Elsevier’s 140+ years’ experience in curating and classifying life science data, the Professional Services team partners with customers to design tailored solutions that address specific needs. Count on Professional Services to:
- Customize data retrieval in order to pinpoint relevant answers in the vast amount of published scientific literature — Discover Elsevier Text Mining
- Optimize data integration and normalization processes that facilitate comparison and analysis
- Harmonize internal and third-party resources to create integrated, customized databases
Ready to take the next step?
How Professional Services helps our customers
Customized data sets for improved discovery
See how a pharmaceutical company was able to rely on a customized database created by the Professional Services team to help find reported mutations in cancer cells.
Read more about customized data (PDF, 715kb)
Support for critical drug repurposing decisions
Find out how the Professional Services team helped breathe new life into a drug by helping a pharmaceutical company assess supporting evidence and find alternative indications.
Read more about supporting critical drug decisions (PDF, 682kb)
Accelerating discovery by integrating disparate data sets
Find out how a pharmaceutical company was able to harvest research data, normalize it and integrate it into a single database boosting accessibility and collaboration.
Read more about integrating disparate data sets (PDF, 693kb)
Compliant monitoring of adverse events
Learn how a pharmaceutical company was able to rely on our comprehensive strategy for screening scientific literature, reporting adverse events and ensuring compliance.
Read more about monitoring adverse events (PDF, 716kb)
Automated retrieval and processing
Find out how Elsevier’s Professional Services team has developed techniques to automate regular updates of internal databases, and retrieving and processing of new information.
Bio-IT World Conference & Expo
May 23-25, 2017 Boston, MA
Visit our booth (#161) and attend our talks at Bio-IT:
Tuesday, May 23 at 12:40 pm Luncheon Presentation I: Towards the Use of Bioassays as Predictors of Adverse Events in Clinical Trials
Matthew Clark, Ph.D., Consultant R&D Solutions, Elsevier
Tuesday, May 23 at 5:00 pm Transforming Disparate Data into Collective Insights
Frederik van den Broek, Ph.D., Consultant, R&D Solutions, Elsevier
Gregory Landrum, Ph.D., Vice President, Life Sciences, Knime.com AG
Find relevant answers, faster
Elsevier Text Mining enables the retrieval of highly specified information from unstructured content, providing more meaningful answers to complex research questions in less time.
Learn more about Elsevier Text Mining
The Hive: Real Stories. Real Science. Real Time.
Biotech and pharma start-ups are using Elsevier's R&D solutions to solve for early-stage drug discovery and development. To find out more, watch the videos, read real-world case studies and learn how early innovation starts with early access to research.
Visit The Hive
Pharma R&D Today blog
Get a wide range of the latest insights and opinions on pharma-related topics with the Elsevier Pharma R&D blog.
Learn about target identification, big data, new drug discovery, drug safety monitoring, risk mitigation, regulatory compliance and much more.
Visit our pharma blog